Insider Purchase by Lappe Mark (Chief Executive Officer)
Trade Summary
2 days ago, Lappe Mark, serving as Chief Executive Officer at Inhibrx Biosciences, Inc. (INBX), purchased 25,000 shares at $105.82 per share, for a total transaction value of $2,645,399.31. Following this transaction, Lappe Mark now holds 730,548 shares of INBX.
This purchase represents a 3.54% increase in Lappe Mark's stake in the company. This is considered a medium-conviction trade.
The trade was executed on Tuesday, September 8, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, September 8, 2026 at 4:04 PM ET, meaning the disclosure happened on the same day as the trade.
Inhibrx Biosciences, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.
Trade Price
$105.82
Quantity
25,000
Total Value
$2,645,399.31
Shares Owned
730,548
Trade Date
2 days ago
SEC Filing Date
at 4:04 PM ET
Discussion